Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02998047
Brief Title: A Phase I Study of Lintuzumab-Ac225 in Patients With Refractory Multiple Myeloma

First Submitted : December 12, 2016
First Submitted that Met QC Criteria : December 16, 2016
First Posted : December 20, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : December 14, 2018
Last Update Posted : December 18, 2018 (Estimate)